Sixty years of follow-up of Hiroshima and Nagasaki survivors: Current progress in molecular epidemiology studies

Mutation Research - Reviews in Mutation Research

Volumn 659, Issue 1-2, 2008, Pages 109-117

  Nakachi, Kei ^a   Hayashi, Tomonori ^a   Hamatani, Kiyohiro ^a   Eguchi, Hidetaka ^a   Kusunoki, Yoichiro ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

Atomic bomb survivors; Colorectal carcinogenesis; Microsatellite instability; Oxidative stress; Radiation; Somatic mutation; Thyroid carcinogenesis

Indexed keywords

B RAF KINASE; GLYCOPHORIN A; HISTONE H2AX;

ATOMIC BOMB SURVIVOR; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLORECTAL CANCER; EPIGENETICS; FOLLOW UP; GENE REARRANGEMENT; INFLAMMATION; JAPAN; MICRONUCLEUS TEST; MICROSATELLITE INSTABILITY; MOLECULAR EPIDEMIOLOGY; ONCOGENE RET; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; RETICULOCYTE; REVIEW; SOMATIC MUTATION; THYROID CANCER; THYROID PAPILLARY CARCINOMA;

DNA DAMAGE; EPIDEMIOLOGY, MOLECULAR; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; JAPAN; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIOACTIVE FALLOUT; SURVIVORS;

EID: 47849124251     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2008.02.001     Document Type: Review

References (41)

1. Kusunoki Y., and Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int. J. Radiat. Biol. 84 (2007) 1-14
2. Kyoizumi S., Kusunoki Y., Hayashi T., Hakoda M., Cologne J.B., and Nakachi K. Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study on erythrocyte glycophorin A gene mutations of atomic bomb survivors. Cancer Res. 65 (2005) 5462-5469
3. Hamasaki K., Imai K., Nakachi K., Takahashi N., Kodama Y., and Kusunoki Y. Short-term culture and γH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ. Mol. Mutagen. 48 (2007) 38-47
4. Hamasaki K., Imai K., Hayashi T., Nakachi K., and Kusunoki Y. Radiation sensitivity and genomic instability in the hematopoietic system: frequencies of micronucleated reticulocytes in whole-body X-irradiated BALB/c and C57BL/6 mice. Cancer Sci. 98 (2007) 1840-1844
5. Hayashi T., Morishita Y., Kubo Y., Kusunoki Y., Hayashi I., Kasagi F., Hakoda M., Kyoizumi S., and Nakachi K. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am. J. Med. 118 (2005) 83-86
6. Takahashi K., Eguchi H., Arihiro K., Ito R., Koyama K., Soda M., Cologne J.B., Hayashi Y., Nakachi K., and Hamatani K. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose. Mol. Carcinogenesis 46 (2007) 242-248
7. Kyoizumi S., Akiyama M., Cologne J.B., Tanabe K., Nakamura N., Awa A.A., Hirai Y., Kusunoki Y., and Umeki S. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic-bomb survivors: implications for radiation carcinogenesis. Radiat. Res. 146 (1996) 43-52
8. Kyoizumi S., Nakamura N., Hakoda M., Awa A.A., Bean M.A., Jensen R.H., and Akiyama M. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res. 49 (1989) 581-588
9. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
10. Rogakou E.P., Boon C., Redon C., and Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146 (1999) 905-916
11. Takahashi A., and Ohnishi T. Does γH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett. 229 (2005) 171-179
12. Ichijima Y., Sakasai R., Okita N., Asahina K., Mizutani S., and Teraoka H. Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. Biochem. Biophys. Res. Commun. 336 (2005) 807-812
13. McManus K.J., and Hendzel M.J. ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol. Biol. Cell 16 (2005) 5013-5025
14. Lorimore S.A., Coates P.J., and Wright E.G. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22 (2003) 7058-7069
15. Grawe J., Zetterberg G., and Amneus H. Flow-cytometric enumeration of micronucleated polychromatic erythrocytes in mouse peripheral blood. Cytometry 13 (1992) 750-758
16. Dertinger S.D., Torous D.K., and Tometsko K.R. Simple and reliable enumeration of micronucleated reticulocytes with a single-laser flow cytometer. Mutat. Res. 371 (1996) 283-292
17. Asano N., Katsuma Y., Tamura H., Higashikuni N., and Hayashi M. An automated new technique for scoring the rodent micronucleus assay: computerized image analysis of acridine orange supravitally stained peripheral blood cells. Mutat. Res. 404 (1998) 149-154
18. Krzyzanski W., and Perez-Ruixo J.J. An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects. Pharm. Res. 24 (2007) 758-772
19. Grawe J., Biko J., Lorenz R., Reiners C., Stopper H., Vershenya S., Vukicevic V., and Hempel K. Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutat. Res. 583 (2005) 12-25
20. Dertinger S.D., Miller R.K., Brewer K., Smudzin T., Torous D.K., Roberts D.J., Avlasevich S.L., Bryce S.M., Sugunan S., and Chen Y. Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat. Res. 626 (2007) 111-119
21. Hayashi I., Morishita Y., Imai K., Nakamura M., Nakachi K., and Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat. Res. 631 (2007) 55-61
22. Thompson D.E., Mabuchi K., Ron E., Soda M., Tokunaga M., Ochikubo S., Sugimoto S., Ikeda T., Terasaki M., Izumi S., and Preston D.L. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (1994) S17-S67
23. Kimura E.T., Nikiforova M.N., Zhu Z., Knauf J.A., Nikiforov Y.E., and Fagin J.A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence of constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 63 (2003) 1454-1457
24. Soares P., Trovisco V., Rocha A.S., Lima J., Castro P., Preto A., Maximo V., Botelho T., Seruca R., and Sobrinho-Simoes M. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathologenesis of PTC. Oncogene 22 (2003) 4578-4580
25. Frattini M., Ferrario C., Bressan P., Balestra D., De Cecco L., Mondellini P., Bongarzone I., Collini P., Gariboldi M., Pilotti S., Pierotti M.A., and Greco A. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene 23 (2004) 7436-7440
26. Nikiforov Y.E., Rowland J.M., Bove K.E., Monforte-Munoz H., and Fagin J.A. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57 (1997) 1690-1694
27. Rabes H.M., Demidchik E.P., Sidorow J.D., Lengfelder E., Beimfohr C., Hoelzel D., and Klugbauer S. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin. Cancer Res. 6 (2000) 1093-1103
28. Xing M. BRAF mutation in thyroid cancer. Endocr. Related Cancer 12 (2005) 245-262
29. Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., and Suarez H.G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15 (1997) 1263-1273
30. Elisei R., Romei C., Vorontsova T., Cosci B., Veremeychik V., Kuchinskaya E., Basolo F., Demidchik E.P., Miccoli P., Pinchera A., and Pacini F. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrin. Metabol. 86 (2001) 3211-3216
31. Mizuno T., Iwamoto K.S., Kyoizumi S., Nagamura H., Shinohara T., Koyama K., Seyama T., and Hamatani K. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene 19 (2000) 438-443
32. Soreide K., Janssen E.A., Soiland H., Korner H., and Baak J.P. Microsatellite instability in colorectal cancer. Br. J. Surg. 93 (2006) 395-406
33. Kuismanen S.A., Holmberg M.T., Salovaara R., de la Chapelle A., and Peltomaki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am. J. Pathol. 156 (2000) 1773-1779
34. Deng G., Chen A., Hong J., Chae H.S., and Kim Y.S. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 59 (1999) 2029-2033
35. Miyakura Y., Sugano K., Konishi F., Ichikawa A., Maekawa M., Shitoh K., Igarashi S., Kotake K., Koyama Y., and Nagai H. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 121 (2001) 1300-1309
36. Furukawa T., Konishi F., Masubuchi S., Shitoh K., Nagai H., and Tsukamoto T. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers. Genes Chromosomes Cancer 35 (2002) 1-10
37. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25 (1997) 2532-2534
38. Hawkins N.J., and Ward R.L. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J. Natl. Cancer Inst. 93 (2001) 1307-1313
39. O'Brien M.J., Yang S., Mack C., Xu H., Huang C.S., Mulcahy E., Amorosino M., and Farraye F.A. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 30 (2006) 1491-1501
40. Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50 (2007) 113-130
41. Hamatani K., Eguchi H., Takahashi K., Koyama K., Mukai M., Ito R., Taga M., Yasui W., and Nakachi K. Improved RT-PCR amplification for molecular analyses with long-term preserved formalin-fixed, paraffin-embedded tissue specimens. J. Histochem. Cytochem. 54 (2006) 773-780